Millennium Management’s Rani Therapeutics RANI Stock Holding History

Millennium Management’s Portfolio RANI Stock Details RANI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-405,669	Closed	-$298K	–	6314
2026 Q1	$298K	Buy	405,669 +242,369	+148%	+$310K	﹤0.01%	5011
2025 Q4	$220K	Buy	+163,300	New	+$246K	﹤0.01%	5425
2024 Q4	–	Sell	-11,447	Closed	-$24.7K	–	6377
2024 Q3	$24.7K	Buy	+11,447	New	+$32.8K	﹤0.01%	5778
2023 Q4	–	Sell	-46,137	Closed	-$100K	–	6453
2023 Q3	$100K	Sell	46,137 -87,324	-65%	-$334K	﹤0.01%	5337
2023 Q2	$550K	Buy	133,461 +58,893	+79%	+$273K	﹤0.01%	4475
2023 Q1	$385K	Buy	74,568 +1,424	+2%	+$8.56K	﹤0.01%	4751
2022 Q4	$432K	Sell	73,144 -15,990	-18%	-$117K	﹤0.01%	4845
2022 Q3	$854K	Sell	89,134 -22,647	-20%	-$240K	﹤0.01%	4473
2022 Q2	$1.16M	Buy	111,781 +79,256	+244%	+$910K	﹤0.01%	4236
2022 Q1	$439K	Buy	+32,525	New	+$540K	﹤0.01%	5227
2021 Q4	–	Sell	-28,996	Closed	-$517K	–	7277
2021 Q3	$517K	Buy	+28,996	New	+$502K	﹤0.01%	5317

Other funds holding RANI

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Longaeva Partners Chicago, Illinois $4.58B AUM 43.91% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

HCM

Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Millennium Management's RANI Position: Q2 2026 in Review

Millennium Management sold out of Rani Therapeutics (RANI) in Q2 2026, closing a stake of 405,669 shares — an estimated $298K sold.

Millennium Management first reported a position in RANI in Q3 2021 and held it in 11 quarters. The position peaked at $1.16M in Q2 2022. 68 funds tracked by Wall St. Rank hold RANI as of Q2 2026.

Millennium Management reported no remaining Rani Therapeutics position as of Q2 2026 after selling out during the quarter.
Millennium Management sold 405,669 Rani Therapeutics shares in Q2 2026, an estimated $298K.
Millennium Management first reported a position in Rani Therapeutics in Q3 2021 and held it in 11 quarters.
Millennium Management's Rani Therapeutics position peaked at $1.16M in Q2 2022.
68 funds tracked by Wall St. Rank held Rani Therapeutics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.